Has Paul Fu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,515 in general payments to Paul Fu, MD across 163 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Fu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Fu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Fu, MD

Neurology · Auburn, NYNPI 1225440688

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,940 of the $4,515 with a category attached, or 65.1%. 25 manufacturers reported payments, led by AstraZeneca at 38.4% of the total. Reporting peaked in 2021 at $1,759 and has fallen 98.5% since, to $26 in 2025.

$4,515in general payments, 2019–2025

Across 163 payments — averaging $27.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$2K
Teva Pharmaceuticals USA, Inc.$408
AbbVie$326
Biohaven Pharmaceuticals, Inc.$308
Lilly USA, LLC$272
EMD Serono, Inc.$180
plus $1K from 19 others

What the payments were for

Consulting fees$1,57535%
Food & beverage$2,94065%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	11	$1,732
Teva Pharmaceuticals USA, Inc.	20	$408
AbbVie(2 entities)	28	$326
Biohaven Pharmaceuticals, Inc.	17	$308
Lilly USA, LLC	13	$272
EMD Serono, Inc.	10	$180
Biogen	7	$158
Novartis	7	$143
SK Life Science, Inc.	6	$127
Bristol Myers Squibb	6	$123
Amgen	5	$100
Johnson & Johnson	4	$83
Sanofi	4	$83
UCB, Inc.	4	$80
Upsher-smith Laboratories LLC	4	$77
Amneal Pharmaceuticals LLC	3	$64
Boehringer Ingelheim	2	$49
E.r. Squibb & Sons, L.L.C.	2	$45
MDD US Operations, LLC	2	$32
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$27
Genentech USA, Inc.	2	$26
Stryker	1	$26
Kyowa Kirin, Inc.	1	$16
Abbott	1	$14
Neurocrine Biosciences, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ULTOMIRIS$1,575
AJOVY$108

How this compares

$4,515 in reported general payments places this provider in the 70th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Medicare billing

Part B allowed, 2024

$9,302

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Auburn

Idan SharonBrooklyn$2.1M
Allan PerelStaten Island$1.7M
Nicolas SaikaliAmherst$1.5M
David KreitzmanCommack$1.5M
Charles ArgoffAlbany$1.2M
Stephen KriegerNew York$1.1M
Robert FeketeHawthorne$1M
Jennifer McVigeAmherst$982K
Warren SpinnerPort Jefferson Station$791K
Richard LiptonBronx$753K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →